REVBW
BASIC MATERIALSRevelation Biosciences Inc
Live · NASDAQ · May 13, Close
What's Moving REVBW Today?
No stock-specific AI insight has been generated for REVBW yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.01
Fundamentals
Trading
REVBW News
20 articles- Revelation Biosciences, Inc. Releases Corporate Update Letter to StockholdersYahoo Finance·May 11, 2026
- REVB Poised for Big YearYahoo Finance·May 8, 2026
- Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026Yahoo Finance·May 7, 2026
- Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory BoardYahoo Finance·Apr 6, 2026
- Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical StudyYahoo Finance·Mar 30, 2026
- REMINDER: Revelation Biosciences to Host Fireside Chat at 38th Annual Roth ConferenceYahoo Finance·Mar 24, 2026
- Revelation Biosciences to Host Fireside Chat at 38th Annual Roth ConferenceYahoo Finance·Mar 19, 2026
- REVB 2026 Starts in Positive FashionYahoo Finance·Feb 27, 2026
- Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025Yahoo Finance·Feb 26, 2026
- REVB Ready to Advance Groundbreaking TreatmentYahoo Finance·Nov 7, 2025
- Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025Yahoo Finance·Nov 6, 2025
- Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record DateYahoo Finance·Oct 29, 2025
- Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025Yahoo Finance·Oct 15, 2025
- Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross ProceedsYahoo Finance·Sep 11, 2025
- Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical DataYahoo Finance·Sep 10, 2025
- Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line DataYahoo Finance·Sep 9, 2025
- Groundbreaking Results from REVB Point to Relief for MillionsYahoo Finance·Sep 9, 2025
- Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical StudyYahoo Finance·Sep 9, 2025
- REVB To Release Test Results This QuarterYahoo Finance·Aug 8, 2025
- Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2025Yahoo Finance·Aug 8, 2025
All 20 articles loaded
Price Data
52-Week Range
$0.01
Fundamentals
Trading
About Revelation Biosciences Inc
Revelation Biosciences Inc is a leading biotechnology firm focused on pioneering therapeutic solutions for respiratory diseases, including allergies and asthma. Utilizing its proprietary research platform, the company aims to address substantial unmet medical needs through innovative R&D initiatives. Committed to improving patient outcomes, Revelation collaborates with key industry stakeholders while navigating the complexities of regulatory compliance in the biopharmaceutical sector. With a robust pipeline of potential therapies, Revelation is strategically poised to make a significant impact on the lives of patients grappling with respiratory conditions.